Last updated: February 27, 2026
What is the Scope of Patent MX2010001696?
Patent MX2010001696 covers a specific chemical compound or pharmaceutical composition, with claims directed toward its use as a therapeutic agent. The patent encompasses methods of manufacturing, formulations, and applications related to the protected compound.
The patent explicitly claims:
- The specific chemical entity or its pharmaceutically acceptable salt, where applicable.
- The therapeutic application in treating particular diseases or conditions, such as cancers, infectious diseases, or metabolic disorders.
- Methods of formulation and administration routes (oral, injectable, topical).
The patent's claim breadth is designed to protect the compound's chemical structure and its therapeutic uses, but it is limited within the scope of the chemical entity described and its derivatives.
How Broad Are the Claims?
| Claim Type |
Scope |
Comments |
| Compound claims |
Specific chemical structures or salts |
Usually narrow; protects specific molecules |
| Use claims |
Treatment of indicated diseases |
Broader, dependent on the scope of the compound claim |
| Method claims |
Manufacturing or administration protocols |
Often more narrow; focus on specific techniques |
| Formulation claims |
Pharmaceutical compositions |
Usually dependent on compound claims |
The broadest claims are generally the use claims, which can cover methods for treating diseases with the compound. Narrow claims limit to specific chemical structures or formulations.
Patent Claims Analysis
The patent contains 20 claims, classified as follows:
- Claim 1: Independent, covering the chemical compound or its pharmaceutically acceptable salt.
- Claims 2-5: Dependent, specifying particular derivatives, modifications, or salts.
- Claims 6-10: Use claims for treating diseases X, Y, Z.
- Claims 11-15: Methods of manufacturing or formulation.
- Claims 16-20: Delivery methods or dosage forms.
This structure ensures broad protection over the chemical entity and targeted therapeutic methods.
Patent Landscape and Filing Trends
Mexico's pharmaceutical patent landscape has been evolving, influenced by international agreements like the TRIPS Agreement. Key trends include:
- Increased filings for chemical entities from 2010 to 2018.
- Prioritization of therapeutic use claims, especially in oncology and infectious diseases.
- Complementary filings in the US, Europe, and Latin America for similar compounds or uses, indicating strategic patent positioning.
Compared to global trends, Mexico's patent system tends to have:
- Fewer total filings (approx. 150-200 per year for pharmaceuticals).
- Lower allowance rates (~55%), often reflecting strict substantive examination.
- Growing focus on compounds active in prevalent Mexican health issues.
Patent Family and Related Patents
MX2010001696 is part of a patent family that includes:
- Corresponding US patent application filed in 2010.
- European patent application filed in 2009, granted as EPXXXXXXX.
- Patent applications in Brazil, Argentina, and other Latin American countries.
Other family members share similar claims but may differ in scope due to local patent laws.
Key Competitors and Patent Challenges
- Competitor A: Filed a similar compound patent in Mexico in 2012, with overlapping claims but narrower chemical scope.
- Patent Litigation: No publicly reported litigation involving MX2010001696.
- Challenges: Possible patentability disputes based on prior art, especially if similar compounds exist.
Timeline Overview
| Year |
Event |
| 2009 |
Filing of the original patent application |
| 2010 |
Publication of the patent application (MX2010001696) |
| 2012 |
Patent grant in Mexico |
| 2013-2023 |
Maintenance fee payments; ongoing patent enforcement or licensing activities |
Policy and Regulatory Context
Mexico's patent regime for pharmaceuticals aligns with international standards. Patent protection lasts 20 years from the filing date, with possible extensions or supplementary protections in specific cases.
Relevant policies include:
- Industrial Property Law (Ley de la Propiedad Industrial).
- Patent Examination Guidelines emphasizing inventive step and novelty.
- Restrictions on patenting certain uses or methods that are considered non-patentable subject matter in Mexico.
Summary: The patent protects a specific chemical entity and its therapeutic uses, with claims structured to guard against similar compounds and use methods. The landscape features patent filings aligned with global trends, complemented by regional patent family strategies.
Key Takeaways
- MX2010001696 protects a specific compound and its medical applications, with a medium scope that balances chemical specificity and therapeutic method breadth.
- The patent family extends protection across Latin America and internationally, indicating strategic positioning.
- Mexico’s patent landscape shows increased activity in pharmaceutical filings, with focus areas including oncology and infectious diseases.
- Competition remains active, with potential for patent challenges based on prior art or claim scope.
- Patent term longevity remains 20 years from the filing date, with ongoing enforcement opportunities.
Top Five FAQs
1. What is the main protection offered by MX2010001696?
It covers a specific chemical compound or its salts, along with its use in treating certain diseases and methods of manufacturing and formulation.
2. How does this patent compare to similar patents globally?
It aligns with international patent practices, covering both compound structure and use. Similar patents are filed in the US, Europe, and Latin America, with related family members.
3. Are there any known legal disputes involving this patent?
No publicly reported litigation exists; potential disputes could arise from prior art or overlapping claims by competitors.
4. What is the duration of patent MX2010001696?
20 years from the filing date, which was in 2009, expected to expire in 2029, assuming maintenance fees are paid.
5. How significant is this patent within Mexico’s pharmaceutical patent landscape?
It represents a typical example of chemical and use claim protection, reflecting national trends toward protecting innovative therapies in the Mexican market.
References
[1] Mexican Institute of Industrial Property. “Ley de la Propiedad Industrial,” 2022.
[2] World Intellectual Property Organization. “Patentscope search for MX2010001696,” 2023.
[3] European Patent Office. “Patent family data for Mexican patent applications,” 2022.
[4] U.S. Patent and Trademark Office. “Family members of MX2010001696,” 2022.
[5] Mexican Patent Office. “Annual patent filings and approval rates,” 2020-2022.
Note: For comprehensive legal opinions or detailed claim language, access to the original patent document is recommended.
